Conference Description:

Join Oxford Global for the 2nd Annual Artificial Intelligence in Drug Development Congress, 25-26 September 2018, London where over 250 artificial intelligence and pharmaceutical IT attendees with represent leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.

Across two days, we will bring together 30 presentations and case studies focussed on the innovatice application of artificial intelligence in drug discovery and discovery chemistry, alongside machine learning in clinical trials and cloud computing.

Including 3 interactive streams:
• AI in Drug Discovery and Discovery Chemistry
• Machine Learning and Personalising Patient Treatments
• AI in Big Data and Clinical Research Development
View Agenda: http://bit.ly/2Bf0OeS
For further information regarding prices and possible discounts, please contact Angela Fernandez on [email protected] or call +44 (0)1865 248 455.